$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Summary of vorasidenib-VORANIGO clinical trial data and efficacy and resistance in different indications
2026-02-01 22:25:32
Check Details
Detailed description of Zongatinib (Zongatinib) indications, main disease types and clinical application guidelines
2026-02-01 22:25:32
Check Details
A complete explanation of the applicable populations and clinical applications of vosoritide
2026-02-01 22:25:32
Check Details
The leukemia targeted drug Gilteritinib has been launched in China, and its clinical efficacy and medication methods are explained in detail
2026-02-01 22:25:32
Check Details
Pomalidomide/octuzumab/zanubrutinib/venetoclax quadruple therapy is effective in high-risk MCL
2026-02-01 22:25:32
Check Details
What is the approximate price of Lapatinib in India and is it worth buying?
2026-02-01 22:25:32
Check Details
What exactly is filgotinib and what is it used for?
2026-02-01 22:25:32
Check Details
What are the effects of selumetinib/coceyu on children?
2026-02-01 22:25:32
Check Details
Pharmacological effects and mechanisms of lorlatinib/lorlatinib (borina)
2026-02-01 22:25:32
Check Details
Differences between the two dosage forms of Cabozantinib
2026-02-01 22:25:32
Check Details
What are the targeted therapeutic genes of bosutinib/bosutinib?
2026-02-01 22:25:32
Check Details
What is the medical insurance reimbursement process for Nintedanib and what should you prepare?
2026-02-01 22:25:32
Check Details
1
2
...
2417
2418
2419
2420
2421
2422
2423
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
ROS and Cancer: The Potential of Natural Antioxidants
2
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
3
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
4
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
5
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
6
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
7
From Causes to Treatments—Exploring Medical Breakthroughs
8
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
9
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
10
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
11
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
12
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope